PL2007347T3 - Kompozycja obejmująca środek do stabilizowania substancji czynnych w wodzie do picia i mieszankę musującą, sposób jej wytwarzania i jej zastosowanie - Google Patents

Kompozycja obejmująca środek do stabilizowania substancji czynnych w wodzie do picia i mieszankę musującą, sposób jej wytwarzania i jej zastosowanie

Info

Publication number
PL2007347T3
PL2007347T3 PL07711695T PL07711695T PL2007347T3 PL 2007347 T3 PL2007347 T3 PL 2007347T3 PL 07711695 T PL07711695 T PL 07711695T PL 07711695 T PL07711695 T PL 07711695T PL 2007347 T3 PL2007347 T3 PL 2007347T3
Authority
PL
Poland
Prior art keywords
agent
composition
production
drinking water
active substances
Prior art date
Application number
PL07711695T
Other languages
English (en)
Inventor
Klaus-Uwe Schwarz
Helge Nestler
Ulrich Bröckel
Michael Iburg
Original Assignee
Lohmann Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Animal Health Gmbh filed Critical Lohmann Animal Health Gmbh
Publication of PL2007347T3 publication Critical patent/PL2007347T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/68—Treatment of water, waste water, or sewage by addition of specified substances, e.g. trace elements, for ameliorating potable water
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
    • C02F2103/02—Non-contaminated water, e.g. for industrial water supply
    • C02F2103/026—Treating water for medical or cosmetic purposes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Water Supply & Treatment (AREA)
  • Hydrology & Water Resources (AREA)
  • Environmental & Geological Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Non-Alcoholic Beverages (AREA)
PL07711695T 2006-02-28 2007-02-27 Kompozycja obejmująca środek do stabilizowania substancji czynnych w wodzie do picia i mieszankę musującą, sposób jej wytwarzania i jej zastosowanie PL2007347T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE102006009338 2006-02-28
DE102006023578 2006-05-19
DE102006054260A DE102006054260A1 (de) 2006-02-28 2006-11-17 Wasser stabilisierende Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung
PCT/EP2007/001679 WO2007098924A2 (de) 2006-02-28 2007-02-27 Zusammensetzung umfassend ein mittel zum stabilisieren von wirkstoffen im trinkwasser und eine brausemischung, verfahren zu deren herstellung und deren verwendung
EP07711695.2A EP2007347B1 (de) 2006-02-28 2007-02-27 Zusammensetzung umfassend ein mittel zum stabilisieren von wirkstoffen im trinkwasser und eine brausemischung, verfahren zu deren herstellung und deren verwendung

Publications (1)

Publication Number Publication Date
PL2007347T3 true PL2007347T3 (pl) 2019-04-30

Family

ID=38434716

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07711695T PL2007347T3 (pl) 2006-02-28 2007-02-27 Kompozycja obejmująca środek do stabilizowania substancji czynnych w wodzie do picia i mieszankę musującą, sposób jej wytwarzania i jej zastosowanie

Country Status (7)

Country Link
EP (1) EP2007347B1 (pl)
JP (1) JP5305199B2 (pl)
DE (1) DE102006054260A1 (pl)
ES (1) ES2709634T3 (pl)
PL (1) PL2007347T3 (pl)
PT (1) PT2007347T (pl)
WO (1) WO2007098924A2 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8631487B2 (en) 2010-12-16 2014-01-14 Research In Motion Limited Simple algebraic and multi-layer passwords
CN110227152A (zh) * 2012-04-23 2019-09-13 巴拉特生物技术国际有限公司 轮状病毒疫苗组合物及其制备方法
WO2016042372A1 (en) 2014-09-17 2016-03-24 Steer Engineering Private Limited Effervescent composition and method of making it
US11219594B2 (en) 2015-12-12 2022-01-11 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof
FR3070684B1 (fr) * 2017-09-04 2020-05-22 Nor-Feed Procede de distribution d'un produit de traitement, par l'intermediaire d'une eau d'abreuvement

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1165098A (en) * 1968-03-25 1969-09-24 H & T Kirby & Company Ltd Improvements in the Preparation of Chlorine-Producing Bactericidal Compositions
GB1221038A (en) * 1969-09-18 1971-02-03 H & T Kirby & Company Ltd Improvements in effervescent tablet compositions
DE3933164B4 (de) * 1988-10-04 2005-08-18 Otsuka Pharmaceutical Co., Ltd. Mittel für eine Eisenzufuhr
ES2060736T3 (es) * 1989-01-12 1994-12-01 Bayer Ag Composicion antiacida analgesica efervescente con un contenido en sodio reducido.
JP2907299B2 (ja) * 1989-09-07 1999-06-21 ゲルゲリイ、ゲルハルト 胃酸を結合する薬学的製剤
JPH0556231U (ja) * 1992-01-07 1993-07-27 雪印乳業株式会社 粉体の溶解装置
DE69726879T2 (de) * 1996-05-17 2004-10-14 Merck & Co., Inc. Biphosphonat-formulierung mit brausewirkung
DE19700368A1 (de) * 1996-07-16 1998-07-09 Lydia Dr Ing Jakubowicz Verfahren zur Herstellung von allgemein zugänglichen stabile Fe·2··+·-Kationen enthaltenden wäßrigen Getränken
AT407008B (de) * 1998-08-06 2000-11-27 Viernstein Helmut Dr Formulierungen mit probiotisch wirksamen mikroorganismen
FR2793685B1 (fr) * 1999-05-19 2001-08-24 Promindus Actions Promotionnel Compositions pharmaceutiques, destinees a l'administration par voie orale de phloroglucinol et leur preparation
AU779403B2 (en) * 1999-08-24 2005-01-20 Teva Pharmaceutical Industries Ltd. A vaccine composition and method of using the same
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
US6485940B2 (en) * 2000-07-07 2002-11-26 Akzo Nobel N.V. Broad spectrum infectious bursal disease virus vaccine

Also Published As

Publication number Publication date
JP2009528311A (ja) 2009-08-06
EP2007347A2 (de) 2008-12-31
PT2007347T (pt) 2019-02-04
EP2007347B1 (de) 2018-11-28
WO2007098924A3 (de) 2007-12-13
DE102006054260A1 (de) 2007-09-27
WO2007098924A2 (de) 2007-09-07
JP5305199B2 (ja) 2013-10-02
ES2709634T3 (es) 2019-04-17

Similar Documents

Publication Publication Date Title
GB2434604B (en) Porous composites containing hydrocarbon-soluble well treatment agents and methods for using the same
IL192053A (en) 2-Admentiluria derivatives as selective inhibitors of 1hsd-β11 and their use in drug preparation
TWI347215B (en) Water dispersion liquid and method for producing the same, and composition, binding agent and coating agent
PL2044076T3 (pl) Sposób wytwarzania asenapiny i związki pośrednie do stosowania w tym sposobie
IL198626A0 (en) Core-1 positive microorganisms, compositions containing the same and methods of use thereof
IL177717A0 (en) Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
EP1946830A4 (en) MICROREACTOR AND METHOD OF LIQUIDATION USING THEREOF
IL212880A0 (en) Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
PL2104422T3 (pl) Inhibicja dojrzewania ostwalda w formulacjach chemicznych
SI2068891T1 (sl) Sestavek, ki obsega gastrolitne komponente rakov, kalcijev karbonat, in njegova uporaba
IL184524A0 (en) Substituted pyrazolo-pyridines, compositions containing them, method for the production thereof, and their use
ZA200801896B (en) Slow-release composition, method for the preparation thereof, and use of the same
IL188278A0 (en) Water soluble analgesic formulations and methods for production
IL185970A0 (en) Composition of spirulinas rich in active ingredients, method for obtaining it and its use
ZA200806361B (en) Methods and compositions for treating feline hyperthyroidism
IL175605A0 (en) Controlled release of topirimate in liquid dosage forms
PT2007347T (pt) Composiçãocompreendendo um agente para estabilizar substâncias activas na água potável, mistura efervescente, método para a sua produção e seu uso
BRPI0722057A2 (pt) Composto, prodroga, composição farmacêutica, método para prevenir ou tratar distúrbio do sono, e, uso do composto.
TWI367761B (en) Pharmaceutical composition containing hardly water soluble pharmaceutical substance
ZA200708530B (en) Pharmaceutical composition and method using antifungal agent in combination
GB2430428B (en) Device and method for the metering of solutions
WO2006116311A3 (en) Opioid receptor agonist compounds and their use in treatment of pain
TWI346671B (en) Chemical composition and process
ZA200805870B (en) One-way valve and apparatus and method of using the valve
EP2057233B8 (de) Neuartige hoch wasserhaltige polyurethane, verfahren zu ihrer herstellung und anwendung